BackBayer AG Overview

Bayer AG Long Term Debt

Latest long-term debt for BAYRY: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-38.43B vs prior year quarter

Peer trimmed avg / median

Loading

Bayer AG Long Term Debt History

Loading

Bayer AG vs. peers: Long Term Debt Comparison

Loading

Bayer AG Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bayer AG (BAYRY) FAQ

Bayer AG's long-term debt stands at $0 as of September 2026. That compares with $38B in the prior-year period — down 100.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bayer AG reported $0 in long-term debt versus $38B a year earlier — a 100.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $38B in the prior-year period — down 100.0% year over year. Sustained growth in long-term debt can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Bayer AG's long-term debt evolved across reporting periods, while the comparison chart places BAYRY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, long-term debt is commonly used to spot outliers. Bayer AG's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.